Accelerating life science innovation and commercialization by leveraging the most advanced AI technology.
Empowering life science with AI for a better human life.
Silexon is an AI technology company driven by the needs for innovation of biotechnology, with a focus on data, empowering life science research to gain a faster, more systematic, and deeper insights into life, health, and diseases, accelerating innovation and commercialization in the field of biotechnology, and addressing the healthcare needs that have yet to be fulfilled.
Patents
Literature
Entity Data
S & L Molecules
TCM Compounds
TCM / Herb Formula
BDE-Pub
INTELLIGENT LITERATURE SEARCH AND ANALYSIS
Uses artificial intelligence and knowledge mapping technologies to help life science research by providing project decision-making reference, implementation solutions and innovative ideas for efficient innovation and R & D.
BDE-Bio
TARGET PRECISE DISCOVERY
Uses AI technology to accurately screen and predict disease diagnosis bio-markers and treatment targets by combining massive literature texts and comprehensive biological data.
BDE-IP
EFFICIENT PATENT MINING
Uses AI technology to realize efficient patent novelty search, feasibility analysis, claims analysis and comparison, knowledge map construction, patent writing and multilingual translation.
BDE-Chem
MOLECULAR GENERATION AND OPTIMIZATION
Automatic extraction and analysis of drug patent / literature data to accelerate the drug development process, and rapid screening of potential active compounds for a given target in a large-scale molecular library based on deep learning models.
BDE-Herb
INNOVATIVE DISCOVERY OF TCM AND HERBAL DRUGS
Discovery of active molecules of traditional Chinese medicine (TCM) and herbs based on deep learning model, clinical analysis of TCM prescriptions (medicinal materials), clinical evaluation of active molecules, druggability analysis, molecular generation or optimization, and process research.
BDE-NA
NUCLEIC ACID DRUG DESIGN
Provides end-to-end solutions for nucleic acid drug design, nucleic acid molecule generation, and optimization, significantly improving key indicators of nucleic acid sequences.
SMALL MOLECULE DRUG DESIGN
Combining the target structure with existing active molecules, following various scenarios such as pharmacochemical principles for molecular generation and optimization.
BDeal
Biotechnology Licensing Assistant
Accelerating the commercial transformation of biotechnology and pharmaceutical IPs with AI-based data analysis of supply - demand correlation.
Licensing In
Licensing Out
Licensing In
Licensing Out
Precisely matching supply with demand among tens of thousands of biotechnology and pharmaceutical firms worldwide based on IP (patent) portfolio, scientific research papers, product pipelines, enterprise situation, investment case analysis.
Licensing In
Licensing Out
Efficiently realizing patent retrieval, automatic data extraction and analysis, claims analysis, knowledge graph construction, patentability research, transformation between technical solutions and patent application documents, and multilingual translation.
Licensing In
Licensing Out
Our Investors
Our Customers / Partners
BDE is a highly intelligent R & D system based on the latest Artificial Intelligence (AI) technology and algorithm models specially trained with large-scale biological data. It can understand, learn, and execute tasks in a wide range of domains, significantly improving the efficiency of life science research and development (up to 90% or more) and reducing costs, including:
General Domains: intelligent literature search and analysis and efficient patent mining that facilitate fund application, scientific research paper drafting and patent filing, etc.
Specialty Domains: analysis of drug targets or biomarkers, small molecule and biological agent (mRNA sequence) design and optimization, TCM and herbal drug discovery, etc.
BDE
(Biological Discovery Engine)